Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cathrin Ritter

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Seminars in Immunopathology|January 12, 2017
T cell receptor repertoire usage in cancer as a surrogate marker for immune responsesDavid Schrama, Cathrin Ritter, Jürgen C Becker
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 6, 2017
Update on the clinical use of kinase inhibitors in melanomaIoana Cosgarea, Cathrin Ritter, Jürgen C Becker, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 6, 2017
Update zum klinischen Einsatz von Inhibitoren mutierter Phosphokinasen beim MelanomIoana Cosgarea, Cathrin Ritter, Jürgen C Becker, et al.
Scientific Reports|February 24, 2016
Reversal of epigenetic silencing of MHC class I chain-related protein A and B improves immune recognition of Merkel cell carcinomaCathrin Ritter, Kaiji Fan, Kelly G Paulson, et al.
Frontiers in Medicine|January 17, 2015
STAT3 Single Nucleotide Polymorphism rs4796793 SNP Does Not Correlate with Response to Adjuvant IFNα Therapy in Stage III Melanoma PatientsDavid Schrama, Selma Ugurel, Antje Sucker, et al.
Plos One|February 25, 2012
Activation of the PI3K/AKT pathway in Merkel cell carcinomaChristian Hafner, Roland Houben, Anne Baeurle, et al.
Journal of Cancer Research and Clinical Oncology|April 14, 2017
MGMT promoter methylation status in Merkel cell carcinoma: in vitro versus invivoGiuseppina Improta, Cathrin Ritter, Angela Pettinato, et al.
Journal of Cancer Research and Clinical Oncology|December 20, 2016
Distribution of TERT promoter mutations in primary and metastatic melanomas in Austrian patientsRichard Ofner, Cathrin Ritter, Barbara Heidenreich, et al.
The Journal of Investigative Dermatology|July 9, 2019
MCPyV Large T Antigen-Induced Atonal Homolog 1 Is a Lineage-Dependency Oncogene in Merkel Cell CarcinomaKaiji Fan, Jan Gravemeyer, Cathrin Ritter, et al.
Journal of Cancer Research and Clinical Oncology|March 19, 2017
Non-reproducible sequence artifacts in FFPE tissue: an experience reportRichard Ofner, Cathrin Ritter, Selma Ugurel, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Seminars in Immunopathology|January 12, 2017
T cell receptor repertoire usage in cancer as a surrogate marker for immune responsesDavid Schrama, Cathrin Ritter, Jürgen C Becker
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 6, 2017
Update on the clinical use of kinase inhibitors in melanomaIoana Cosgarea, Cathrin Ritter, Jürgen C Becker, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 6, 2017
Update zum klinischen Einsatz von Inhibitoren mutierter Phosphokinasen beim MelanomIoana Cosgarea, Cathrin Ritter, Jürgen C Becker, et al.
Scientific Reports|February 24, 2016
Reversal of epigenetic silencing of MHC class I chain-related protein A and B improves immune recognition of Merkel cell carcinomaCathrin Ritter, Kaiji Fan, Kelly G Paulson, et al.
Frontiers in Medicine|January 17, 2015
STAT3 Single Nucleotide Polymorphism rs4796793 SNP Does Not Correlate with Response to Adjuvant IFNα Therapy in Stage III Melanoma PatientsDavid Schrama, Selma Ugurel, Antje Sucker, et al.
Plos One|February 25, 2012
Activation of the PI3K/AKT pathway in Merkel cell carcinomaChristian Hafner, Roland Houben, Anne Baeurle, et al.
Journal of Cancer Research and Clinical Oncology|April 14, 2017
MGMT promoter methylation status in Merkel cell carcinoma: in vitro versus invivoGiuseppina Improta, Cathrin Ritter, Angela Pettinato, et al.
Journal of Cancer Research and Clinical Oncology|December 20, 2016
Distribution of TERT promoter mutations in primary and metastatic melanomas in Austrian patientsRichard Ofner, Cathrin Ritter, Barbara Heidenreich, et al.
The Journal of Investigative Dermatology|July 9, 2019
MCPyV Large T Antigen-Induced Atonal Homolog 1 Is a Lineage-Dependency Oncogene in Merkel Cell CarcinomaKaiji Fan, Jan Gravemeyer, Cathrin Ritter, et al.
Journal of Cancer Research and Clinical Oncology|March 19, 2017
Non-reproducible sequence artifacts in FFPE tissue: an experience reportRichard Ofner, Cathrin Ritter, Selma Ugurel, et al.
Pageof 3